Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Imc Mortgage Co
IMCC | US
0.28
USD-0.02
-5.24%
IMCC | US
About Imc Mortgage Co
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
24/04/2026
Close
0.28
Open
0.28
High
0.30
Low
0.26
IM Cannabis Corp. engages in breeding growing and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower pre-rolls minis and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv Israel.
View LessIMCC | US
Risk
135.7
Sharpe
-0.55
Luna's Score
34/100
Recommendation
Sell
Luna says (IMCC | US)
What's Working
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
109.2%1 month
135.7%3 months
115.6%6 months
122.4%Returns
Fundamental Ratios
PE
-
Fwd. PE
16.31
Price to book
0.90
Debt to equity
2.23
Debt to assets
0.39
Ent. to EBITDA
-1.31
Ent. to rev.
0.43
PEG
-
Other Fundamentals
EBITDA
-11.03M
MarketCap
645.61K
MarketCap(USD)
645.61K
Div. yield
-
Op. margin
-19.58
Erngs. growth
-
Rev. growth
11.70
Ret. on equity
-112.01
Short ratio
0.26
Short perc.
0.23
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.29
Range1M
0.37
Range3M
1.22
Volumes: Market Activity
Rel. volume
1.00
Price X volume
272.23K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.31 | - | Cheaper |
| Ent. to Revenue | 0.43 | - | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.90 | 13.15 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 115.56 | - | Riskier |
| Debt to Equity | 2.23 | -1.88 | Expensive |
| Debt to Assets | 0.39 | 0.48 | Par |
| Market Cap | 645.61K | - | Emerging |
